Scarica l'app Stockscreener
13.62
4.85%
0.63
Dopo l'orario di chiusura:
13.57
-0.05
-0.37%
Precedente Chiudi:
$12.99
Aprire:
$13.89
Volume 24 ore:
1.88M
Relative Volume:
0.48
Capitalizzazione di mercato:
$1.51B
Reddito:
$631.73M
Utile/perdita netta:
$-239.78M
Rapporto P/E:
-6.7426
EPS:
-2.02
Flusso di cassa netto:
$-33.45M
1 W Prestazione:
+10.11%
1M Prestazione:
+26.23%
6M Prestazione:
-8.59%
1 anno Prestazione:
-28.20%
Intervallo 1D:
$13.54
$14.03
Intervallo di 1 settimana:
$11.45
$14.03
Portata 52W:
$6.78
$24.76
10 X Genomics Inc Stock (TXG) Company Profile
Nome
10 X Genomics Inc
Settore
Industria
Telefono
(925) 401-7300
Indirizzo
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Confronta TXG con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TXG
10 X Genomics Inc
|
13.62 | 1.60B | 631.73M | -239.78M | -33.45M | -2.02 |
|
VEEV
Veeva Systems Inc
|
286.01 | 46.61B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
64.86 | 10.57B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
96.91 | 8.42B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
61.00 | 11.13B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
36.96 | 6.33B | 906.14M | -52.62M | 89.62M | -0.3621 |
10 X Genomics Inc Stock (TXG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-13 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-09-03 | Iniziato | Leerink Partners | Outperform |
| 2024-07-22 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-07-18 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-07-10 | Downgrade | Deutsche Bank | Buy → Hold |
| 2024-06-27 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-05-01 | Downgrade | TD Cowen | Buy → Hold |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-05-10 | Iniziato | Barclays | Overweight |
| 2023-03-31 | Iniziato | Stephens | Overweight |
| 2023-02-02 | Iniziato | UBS | Neutral |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-08-18 | Downgrade | Goldman | Neutral → Sell |
| 2022-07-25 | Iniziato | Canaccord Genuity | Buy |
| 2022-07-15 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-07-15 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-09-14 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-03-15 | Iniziato | William Blair | Outperform |
| 2020-12-02 | Iniziato | Goldman | Neutral |
| 2020-09-09 | Iniziato | Morgan Stanley | Overweight |
| 2020-07-10 | Iniziato | Stifel | Buy |
| 2020-03-05 | Iniziato | Guggenheim | Buy |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-10-07 | Iniziato | BofA/Merrill | Buy |
| 2019-10-07 | Iniziato | Cowen | Outperform |
| 2019-10-07 | Iniziato | JP Morgan | Overweight |
| 2019-09-24 | Iniziato | Evercore ISI | Outperform |
Mostra tutto
10 X Genomics Inc Borsa (TXG) Ultime notizie
What analysts say about 10x Genomics Inc. stockOutperformance with explosive growth - Autocar Professional
Fortrea, Azenta, Bio-Techne, 10x Genomics, and Amphastar Pharmaceuticals Stocks Trade Up, What You Need To Know - Yahoo Finance
Is 10x Genomics Inc. a good long term investmentSkyrocketing returns - jammulinksnews.com
10x Genomics Inc. Stock Analysis and ForecastFree Stock Index Interpretation - jammulinksnews.com
What drives 10x Genomics Inc. stock priceBreakout profit opportunities - jammulinksnews.com
10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study - Agency for Science, Technology and Research
Thermo Fisher, Exact Sciences, Integer Holdings, Revvity, and 10x Genomics Shares Are Falling, What You Need To Know - Yahoo Finance
10x Genomics Ends UPC Patent Fight With Bruker - Law360
10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery - the-scientist.com
Why 10x Genomics Inc. stock attracts strong analyst attentionFree Market Sentiment Analysis - beatles.ru
Acadia Healthcare, 10x Genomics, Amphastar Pharmaceuticals, Myriad Genetics, and QuidelOrtho Stocks Trade Down, What You Need To Know - Yahoo Finance
10x Genomics to Report Second Quarter 2025 Financial Results on August 7, 2025 - BioSpace
10x Genomics Reaches Analyst Target Price - Nasdaq
10x Genomics(TXG) Soars 7.88% on Strong Q1 Earnings - AInvest
10x Genomics Insiders Sold US$768k Of Shares Suggesting Hesitancy - 富途牛牛
10x Genomics, Inc.(NasdaqGS: TXG) dropped from Russell 1000 Value Index - MarketScreener
10x Genomics, Inc.(NasdaqGS: TXG) dropped from Russell 1000 Dynamic Index - MarketScreener
10x Genomics (TXG) Receives a Hold from Bank of America Securities - The Globe and Mail
10x Genomics (TXG) Analyst Maintains Rating but Raises Price Target | TXG Stock News - GuruFocus
10x Genomics: Stuck In Neutral (NASDAQ:TXG) - Seeking Alpha
11 Best Genomics Stocks to Buy According to Hedge Funds - Insider Monkey
Revenues Not Telling The Story For 10x Genomics, Inc. (NASDAQ:TXG) After Shares Rise 31% - simplywall.st
10x Genomics Inc (TXG) Trading 4.12% Higher on Jun 18 - GuruFocus
UPC Backs Sales Ban On Kits Infringing 10x Genomics Patent - Law360
Delta, Macy's, CECO Environmental, RadNet, and 10x Genomics Shares Skyrocket, What You Need To Know - Yahoo Finance
Layoff Tracker: Gilead Cuts 36 Employees in California - BioSpace
Molecular Diagnostics for Cancer Market Research 2025: Advances in Personalized Medicine and Liquid Biopsies Reshape Industry Landscape - GlobeNewswire Inc.
Brown Capital Management Small Company Fund Sold 10x Genomics (TXG) Due to Fundamental Concerns - Insider Monkey
10x Genomics, Inc. (TXG) Stock Analysis: Evaluating A 28% Potential Upside For Investors - DirectorsTalk Interviews
Forecasting The Future: 7 Analyst Projections For 10x Genomics - Benzinga
Long Read Sequencing Market Key Players Analysis10X Genomics, - openPR.com
10x Genomics, Inc. (NASDAQ:TXG) Stock Holdings Increased by Deutsche Bank AG - Defense World
ARK Investment Acquires 290K Shares of 10x Genomics (TXG) | TXG Stock News - GuruFocus
10 X Genomics Inc Azioni (TXG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):